AbbVie to present solid tumor data at 2026 ESMO Congress
AbbVie says it will present data highlighting progress across its expanding solid tumor portfolio at the 2026 European Society for Medical Oncology Congress.
AbbVie says it will present data highlighting progress across its expanding solid tumor portfolio at the 2026 European Society for Medical Oncology Congress.